Open AccessTwelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients
Author(s) -
Nicolás Manito,
Juan F. Delgado,
María G. CrespoLeiro,
José M. Arizón,
Javier Segovia,
Francisco GonzálezVílchez,
Sònia Mirabet,
E. Lage,
Domingo A. PascualFigal,
Beatriz Díaz,
Jesús Palomo,
Gregorio Rábago,
María Luisa Sanz-Larruga,
Teresa Blasco,
Eulàlia Roig
Publication year - 2015
Publication title -
world journal of transplantation
Language(s) - English
Resource type - Journals
ISSN - 2220-3230
DOI - 10.5500/wjt.v5.i4.310
Subject(s) - calcineurin , medicine , everolimus , nephrotoxicity , urology , heart transplantation , creatinine , tacrolimus , gastroenterology , transplantation , surgery , toxicity
To determine the clinical reasons for conversion to everolimus (EVL) and long-term outcomes in heart transplant (HT) recipients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom